Your session is about to expire
← Back to Search
Other
Ketogenic Diet in Patients With Untreated Low Tumor Burden Mantle Cell Lymphoma
N/A
Waitlist Available
Led By Peter Martin, M.D.
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if patients with a specific type of cancer can follow a high-fat, low-carb diet for a few months. The diet aims to make the body use fat instead of carbs for energy. Researchers will monitor how well patients stick to the diet and its effects on their health.
Eligible Conditions
- Mantle Cell Lymphoma
- Ketogenic Diet
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of subjects who adhere to ketogenic diet
Secondary study objectives
Effect of ketogenic diet on gut microbiome
Number of subjects who achieve a partial or complete response
Number of subjects who complete quality of life questionnaires at required timepoints
+8 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: All SubjectsExperimental Treatment1 Intervention
Low tumor burden, treatment-naïve MCL
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,091 Previous Clinical Trials
1,154,745 Total Patients Enrolled
Peter Martin, M.D.Principal InvestigatorWeill Medical College of Cornell University